Pharmacological Aspects of the Acetylcholinesterase Inhibitor Galantamine

The role of BDNF in depression on the basis of its location in the neural circuitry

(2010) Hui Yu et al.   ACTA PHARMACOLOGICA SINICA

Involvement of decreased muscarinic receptor function in prepulse inhibition deficits in mice reared in social isolation

(2010) K Koda et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry

(2010) Å. Konradsson-Geuken et al.   NEUROSCIENCE

Cognitive enhancement as a pharmacotherapy target for stimulant addiction

(2009) Mehmet Sofuoglu   ADDICTION

Galantamine improves apomorphine-induced deficits in prepulse inhibition via muscarinic ACh receptors in mice

(2009) K Yano et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Double-Blind, Placebo-Controlled Pilot Study of Galantamine to Improve Cognitive Dysfunction in Minimally Symptomatic Bipolar Disorder

(2009) S. Nassir Ghaemi et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Increased glutamate in the hippocampus after galantamine treatment for Alzheimer disease

(2009) Jacob Penner et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY